Literature DB >> 893430

Human lymphoblastoid interferon. Large scale production and partial purification.

P J Bridgen, C B Anfinsen, L Corley, S Bose, K C Zoon, U T Rüegg, C E Buckler.   

Abstract

Human lymphoblastoid interferon was produced on an 800-liter scale (2.6 X 10(9) units) by induction of Namalva cells with Newcastle disease virus, strain B1. The interferon was partially purified by anti-leukocyte interferon affinity chromatography, sulfopropyl Sephadex ion exchange chromatography, isoelectric focusing, and sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Recovery of interferon after gel electrophoresis varied from 11 to 33% based on the original crude material, with about 35,000-fold purification. The gel electrophoresis resolved the antiviral activity into two components with apparent molecular weights of 18,000 and 22,000; treatment with glycosidases resulted in all the activity being associated with the lower molecular weight species. Interferon activity could be completely (85 to 113%) recovered from the gels by elution into a buffer containing sodium dodecyl sulfate. The presence of sodium dodecyl sulfate did not appear to affect the assay of interferon. The protein could also be completely (75 to 106%) eluted from gels stained with coomassie blue, again with no loss in activity.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 893430

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Interferoids: in vitro and in vivo conversion of native interferons to lower molecular weight forms.

Authors:  W E Stewart; T Chudzio; L S Lin; M Wiranowska-Stewart
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

2.  Purification and partial characterization of human lymphoblast interferon.

Authors:  K C Zoon; M E Smith; P J Bridgen; D zur Nedden; C B Anfinsen
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

3.  Large-scale production and concentration of human lymphoid interferon.

Authors:  F Klein; R T Ricketts; W I Jones; I A DeArmon; M J Temple; K C Zoon; P J Bridgen
Journal:  Antimicrob Agents Chemother       Date:  1979-03       Impact factor: 5.191

Review 4.  Interferon: therapeutic fact or fiction for the '80s?

Authors:  G M Scott; D A Tyrrell
Journal:  Br Med J       Date:  1980-06-28

5.  Enzymatic modifications of human fibroblast and leukocyte interferons.

Authors:  M J Otto; J J Sedmak; S E Grossberg
Journal:  J Virol       Date:  1980-08       Impact factor: 5.103

Review 6.  Differences between human alpha (leukocyte) and beta (fibroblast) interferons.

Authors:  T G Hayes
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

7.  The absence of introns within a human fibroblast interferon gene.

Authors:  M Houghton; I J Jackson; A G Porter; S M Doel; G H Catlin; C Barber; N H Carey
Journal:  Nucleic Acids Res       Date:  1981-01-24       Impact factor: 16.971

8.  Differential expression of human interferon genes.

Authors:  J Hiscott; K Cantell; C Weissmann
Journal:  Nucleic Acids Res       Date:  1984-05-11       Impact factor: 16.971

9.  Sepharose-immobilized triazine dyes as adsorbants for human lymphoblastoid interferon purification.

Authors:  P J Neame; I Parikh
Journal:  Appl Biochem Biotechnol       Date:  1982-07       Impact factor: 2.926

Review 10.  Suppressin: an endogenous negative regulator of immune cell activation.

Authors:  E M Ban; R D LeBoeuf
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.